Skip to content

Clinical trials

Diabetic Retinopathy trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Country / region: Australia Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20121
20131
20162
20172
20181
20201
20211
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Active, not recruiting2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sydney5
Center for Eye Research Australia2
Bausch & Lomb Incorporated1
Boehringer Ingelheim1
Chromaderm, Inc.1
GlaxoSmithKline1
Hoffmann-La Roche1
Lions Eye Institute, Perth, Western Australia1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy17
Macular Edema4
Retinal Diseases4
Diabetes Mellitus3
Glaucoma2
Macular Degeneration2
Diabetes Mellitus, Type 11
Diabetic Nephropathies1
Retinal Dystrophies1
Retinitis Pigmentosa1

Trials

Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.